Free Trial

Immatics (IMTXW) Competitors

Immatics logo
$0.02 0.00 (0.00%)
As of 05/23/2025

IMTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Immatics vs.

180 Life Sciences (NASDAQ:ATNFW) and Immatics (NASDAQ:IMTXW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Immatics$144.15MN/AN/AN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Immatics'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Immatics Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Immatics N/A N/A N/A

180 Life Sciences and Immatics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
ImmaticsN/AN/A

Summary

Immatics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMTXW vs. The Competition

MetricImmaticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$128.95M$5.34B$8.31B
Dividend YieldN/A3.74%5.27%4.10%
P/E RatioN/A3.4726.9619.60
Price / SalesN/A4,168.74396.61135.04
Price / CashN/A13.1938.3234.64
Price / BookN/A33.216.774.50
Net IncomeN/A-$91.56M$3.24B$248.60M
7 Day PerformanceN/A2.81%0.27%-0.88%
1 Month PerformanceN/A6.84%6.59%7.89%
1 Year PerformanceN/A102.24%18.46%8.60%

Immatics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMTXW
Immatics
N/A$0.02
flat
N/AN/A$0.00$144.15M0.00260
ATNFW
180 Life Sciences
N/A$0.01
-2.4%
N/A-21.1%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+205.4%
N/A-87.8%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.12
-21.9%
N/AN/A$0.00$20,729.000.0040News Coverage
ALVOW
Alvotech
N/A$1.80
-3.2%
N/A-38.8%$0.00$585.60M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/A-78.9%$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.18
+25.0%
N/A+72.0%$0.00$37.32M0.0070Gap Up
BTMDW
biote
N/A$0.03
+6.3%
N/AN/A$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.09
+15.5%
N/A-81.7%$0.00N/A0.008High Trading Volume
CELUW
Celularity
N/A$0.05
flat
N/AN/A$0.00$54.22M0.00220

Related Companies and Tools


This page (NASDAQ:IMTXW) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners